Results 231 to 240 of about 1,495,069 (363)

Papillary thyroid carcinoma

, 2012
Mostafa El-Feky, Garth Kruger
openaire   +1 more source

Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases

Modern Pathology, 2018
Nadjla Alsadoun, G. MacGrogan, C. Truntzer, M. Lacroix-Triki, I. Bedgedjian, M. Koeb, E. El Alam, D. Medioni, Michel Parent, P. Wuithier, I. Robert, R. Boidot, L. Arnould   +12 more
semanticscholar   +1 more source

Modulation of RASD2 by miRNA‐485‐5p Drives Thyroid Cancer Progression and Metastasis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT This study investigates the role of RASD2 (Ras Homolog Enriched In Striatum) in thyroid carcinoma progression and its modulation by microRNA‐485‐5p. Differential RASD2 expression patterns were initially identified through bioinformatic analysis of public databases.
Xiao‐Yu Li, Jian‐Ping Sun, Hao Guo, Xiao‐Qing Fan, Shan‐Shan Zhang, Bo Wang, Na Yu, Qing‐Huai Li   +7 more
wiley   +1 more source

Eosinophils but not mast cells exert anti-tumorigenic activity, without being predictive markers of the long-term response to Bacillus Calmette-Guérin (BCG) therapy in patients with bladder carcinoma. [PDF]

Inflamm Res
Zaffran I, Zoabi Y, Gaur P, Alekberli FR, Tiligada E, Yutkin V, Levi-Schaffer F.   +6 more
europepmc   +1 more source

Otolaryngologic Side Effects of GLP‐1 Receptor Agonists

The Laryngoscope, EarlyView.
Objectives With the increasing use of GLP‐1 receptor agonist (GLP‐1 RA) drugs for weight loss and diabetes management, concerns have been raised regarding their potential side effects. We aim to assess the frequency of otolaryngologic adverse events (AEs). Study Design Retrospective analysis of national registry.
Faizaan I. Khan, Sebastian Guadarrama‐Sistos Vazquez, Zain Mehdi, Isuru Somawardana, Roshan Dongre, Samuel Razmi, Keyvon Rashidi, Jason Shenoi, Najm Khan, Aatin Dhanda, Masayoshi Takashima, Omar G. Ahmed   +11 more
wiley   +1 more source

Expression of concern "A ceRNA network mediated by LINC00475 in papillary thyroid carcinoma". [PDF]

Open Med (Wars)
Editors of Open Medicine.
europepmc   +1 more source

Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-lik

Modern Pathology, 2017
Uiju Cho, O. Mete, Min-Hee Kim, J. Bae, C. Jung   +4 more
semanticscholar   +1 more source

Cytological Alterations of Benign Thyroid Nodules Following Radiofrequency Ablation

The Laryngoscope, EarlyView.
This prospective study of 312 patients with benign thyroid nodules treated with radiofrequency ablation showed a 3.84% progression to Bethesda III cytology, all confirmed benign by molecular testing, with an 88% volume reduction at 60 months and no major complications.
Emad Kandil, Mohammad H. Hussein, Kavin Sugumar, Milee Patel, Marika Russell, Gregory Randolph, Eman A. Toraih   +6 more
wiley   +1 more source

Papillary Renal Cell Carcinoma With Widespread Metastases in an Arabian Mare. [PDF]

Vet Med Sci
Azari O, Ghamsari SM, Roustaei A, Golchin D, Baharloo F, Javaheri M, Valizadeh N.   +6 more
europepmc   +1 more source

Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology

Cancer Cytopathology, 2016
W. Faquin, Lawrence Q. Wong, A. Afrogheh, Syed Z. Ali, J. Bishop, M. Bongiovanni, M. Pusztaszeri, C. VandenBussche, Jolanta Gourmaud, L. Vaickus, Z. Baloch   +10 more
semanticscholar   +1 more source